Clinical trial
Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and…
NCT00289354 · Nutrition 21, Inc., Industry · Completed
Key facts
| NCT number | NCT00289354 |
|---|---|
| Title | Efficacy and Safety Study of Chromium Picolinate + Biotin on Glucose and Cholesterol Control in T2DM |
| Official title | Randomized, Double Blinded, Placebo Controlled, Study to Evaluate Improvements in Glycemic Control, Lipid Levels, Quality of Life and Healthcare Costs After Daily Administration of Chromium Picolinate and Biotin in Patients With T2DM |
| Lead sponsor | Nutrition 21, Inc., Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Chromium Picolinate (600 mcg Cr) + biotin (2 mg) |
| Enrollment | 600 |
| Start date | Mar 1, 2003 |
| Completion | Nov 1, 2005 |
| First posted | Feb 9, 2006 |
| Last update posted | Feb 9, 2006 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: